ClinicalTrials.gg
Not yet recruitingNCT07011407Updated Jun 8, 2025

The FACIAL Study Pilot

An observational study in Healthy Adult, sponsored by Lancaster University. Not yet recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-08.

Sponsored by Lancaster University · Observational

From the registry’s dates

  • Primary completion was expected by Aug 2025, 1 year 3 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
15
Ages
18 Years to 35 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 387 studies in Motor Activity with a site in United Kingdom — 62 open to participants now, 76 under way, none of them phase 3. Motor Activity · United Kingdom.

Planned enrollment
64th of 71
15 · median 60
Started
2025
with 24 others
Observational
71 of 387
13 open now
Primary completion
2025-08
later than 26 of 75 live
Registered
360th of 387
by date

Among the 387 studies in Motor Activity with a site in United Kingdom, this one is the 64th largest by planned enrollment of the 71 observational ones, is one of 25 that started in 2025, is one of 71 observational ones, reaches primary completion later than 26 of the 75 other live ones, and was the 360th registered.

By phase

387 studies; the count open now beside each. This study's row is marked.

No phase290 · 48 open
Observationalthis study71 · 13 open
Phase 29 · 0 open
Phase 17 · 1 open
Phase 34 · 0 open
Phase 1/22 · 0 open
Phase 2/32 · 0 open
Phase 42 · 0 open

By the year they started

First in 2002; this study’s year is marked. 25 started in 2025.

Size and results

Median enrollment 42 across the 316 interventional studies, 60 across the 71 observational. Of the 248 that completed or were terminated, 21 (8%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 387 studies in Motor Activity with a site in United Kingdom, or all of them as a file.
02

Study summary

Facial recognition is a non-invasive method for analysing facial characteristics and changes in facial expressions. There is evidence to suggest there may be a link between physiological health and facial expression patterns. Many medical conditions are associated with specific facial characteristics, with some related to inherited genetic conditions and others that have been acquired as a result of medical conditions such as stroke, nerve injuries and dementia. If successful, this technology could prove useful for studies evaluating the monitoring of acute or chronic illness. The proposed study will ask participants to do a maximal exercise test that will challenge the body, as a proof-of-principle, to see how this correlates with facial expressions. Depending on the study outcomes and future work, it could prove to be a useful tool and clinical application in healthcare for evaluating and tracking patient health and well-being. The investigators want to conduct a proof-of-principle study where physically stressed young and healthy participants (in the form of a maximal exercise test), whilst recording facial expressions, will be used to determine the relationship between physiological stress and changes in facial parameters.

Read the detailed description

For this pilot study, no specific sample size calculation is required for this pilot study as this will recruit 15 participants for proof of concept. The outcomes from this research will lead to the identification of measurement parameters to be evaluated in future studies concerning facial characteristics and their parameters. This will inform the next steps in the application of the process to further healthy participants with the ultimate aim to translate this to research on a range of patient populations in elective and acute medical settings.

Video and still image capture will be undertaken using a camera mounted on a tripod in front of the participant whilst they are exercising. The data analysis mainly consists of four processing stages, including facial landmark detection, facial region identification, region-based facial analysis and data correlations, as illustrated in the diagram below. The facial landmark detection can label a total of 68 points in each face, which are in the predefined locations. Based on the facial landmark, the region identification can segment the face into different areas, such as brows, eyes, chin, etc. Then, the region-based analysis can be applied to facial data and extracts the geometry, colour, emotion and temperature information of the individual facial region and calculates their variations against time. Finally, vital sign reading and region-based facial data are analysed together by using statistical tools in order to identify their correlations and demonstrate how facial appearances change in different scenarios.

Lancaster University is the data owner/controller, and UCLAN will follow Lancaster's requirements of data management when the data is processed. The data will be transferred on an encrypted hard drive and stored on secure online storage by UCLAN data protection rules. The data will only be accessible to the FACIAL study collaborators and statisticians. Whilst sociodemographic and physiological data can be anonymised, the video recordings of facial expressions cannot. The two sets of data will be provided with separate research codes so that protected data cannot be linked to identities by anyone other than the study team. Processing of protected data such as ethnicity and biometric data is central to the research question and ultimately, might have efficacy in the treatment of high dependency patients in hospital care.

The FACIAL Study protocol has been formulated and reviewed by the FACIAL Steering Committee, and research will be carried out in line with the University of Central Lancashire and Lancaster University code of ethics. The FACIAL study will be carried out by the FACIAL steering committee as a collaboration between East Lancashire Hospitals NHS Trust, Lancaster University and the University of Central Lancashire.

The findings from this study will be presented at national or international conferences. Any facial images used for publication will be obtained with additional consent from the individuals. Manuscript(s) will be prepared for submission to a peer-reviewed journal.

03

Conditions studied

  • Healthy Adult

Browse trials for

Keywords

  • Facial Characteristics
  • Exercise
  • Thermal Patterns
  • Facial Expression
  • Maximal Exercise Test
04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy participants from the general public, inlcuding students and staff from the university.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 to 35
  • Male or female
  • Capable of completing a maximal exercise test
  • Answer "NO" to all variables in the Physical Activity Readiness questionnaire (PAR-Q)

Exclusion criteria

Exclusion Criteria:

  • Musculoskeletal injury
  • Cardiovascular disease
  • Neurological disease, stroke, or other disease that may affect facial expressions
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
15 participants (estimated)
Patient registry
No

Interventions

  • OtherMaximal Exercise Test

    Healthy participants will be situated on a cycle ergometer fitted with a 12-lead ECG or chest-strap heart rate monitor. Data from the questionnaire will be stored in a study site file in a locked cabinet in an office. Baseline readings will be obtained whilst on the bike for 3 minutes before the subject embarks on a 3-minute warm-up at 50 Watts (W). The workload (watts) on the bike is then increased to a workload that corresponds to a heart rate of 120 bpm (gentle exercise). The workload will then be increased by 25-50W every three minutes until volitional exhaustion. Between each stage, there will be a 30s rest period where the participant will be cycling with minimal resistance ("freewheeling") but will be otherwise stationary on the cycle ergometer. Still images of the face and facial video recordings will be taken during a 30s rest period between increases in exercise intensity. A finger-prick blood sample (glucose \& lactate) will be taken at the beginning and every 3 minutes.

06

What researchers measure

Primary outcomes

  1. Change in distance between facial features

    Change in inter-feature distance (e.g., between eyes, mouth corners) during different phases of exercise, captured using video and still images to detect facial regions and landmarks. Unit: millimetres (mm).

    Time frame: 60 minutes

  2. Change in size and shape of facial features

    Change in facial feature dimensions (e.g., width and height of eyes, mouth) and geometric shape indices during different phases of exercise. Additionally, captured using video and still images to detect facial regions and landmarks. Units: millimetres² or shape index (unitless).

    Time frame: 60 minutes

  3. Change in facial blood flow patterns

    Regional blood flow variation across facial regions during exercise, captured through thermal imaging. Unit: perfusion units or arbitrary units (a.u.)

    Time frame: 60 minutes

  4. Change in facial temperature

    Alterations in surface temperature across facial regions during exercise, measured with thermal imaging. Units: degrees Celsius (°C)

    Time frame: 60 minutes

  5. Change in facial skin colour

    Variation in facial colour intensity and hue across regions during exercise, analysed from captured video, thermal imaging and still images. Unit of measure: RGB values

    Time frame: 60 minutes

Secondary outcomes

  1. Change in heart rate

    Heart rate is recorded at rest, during exercise, and during recovery. Units: Beats per minute (bpm)

    Time frame: 60 minutes

  2. Change in heart rate variability (HRV)

    Analysis of time and frequency domain HRV indices during different exercise stages. Units: Milliseconds (ms)

    Time frame: 60 minutes

  3. Change in blood glucose

    Blood glucose levels are recorded at rest, during exercise, and recovery. Unit: millimoles per litre (mmol/L)

    Time frame: 60 minutes

  4. Change in Blood Lactate

    Blood lactate recorded at rest, during exercise, and recovery. Units: millimoles per litre (mmol/L)

    Time frame: 60 minutes

07

Study locations

1 site
  • Faculty of Health and Medicine, Lancaster University
    Lancaster, Lancashire LA1 4YW, United Kingdom
08

References and documents

Individual participant data

Plan to share: No — This pilot study is a proof-of-principle study where we physically stress young, healthy participants (in the form of a maximal exercise test), whilst recording facial expressions, to determine the relationship between physiological stress and changes in facial parameters. The code developed from this pilot will be used as part of a PhD project at UCLan and is therefore novel. Individual participant data will not be shared externally at this time.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2025; primary completion for Aug 2025, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
May 29, 2025
First posted
Jun 8, 2025
StartEst.
Jun 1, 2025
Primary completionEst.
Aug 12, 2025
CompletionEst.
Dec 31, 2025
Last update
Jun 8, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07011407
Lead sponsor
Lancaster University
Collaborators
University of Central Lancashire, East Lancashire Hospitals NHS Trust
Responsible party
Dr. Chris Gaffney (Senior Lecturer in Integrative Physiology, Lancaster University) — Principal investigator
First posted
Jun 8, 2025
Start date
Jun 1, 2025 (estimated)
Primary completion
Aug 12, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Jun 8, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion